Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION HYDROBROMIDE vs BUROSUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPROPION HYDROBROMIDE vs BUROSUMAB: Safety Overview

Metric BUPROPION HYDROBROMIDE BUROSUMAB
Total FAERS Reports 235 674
Deaths Reported 23 6
Death Rate 9.8% 0.9%
Hospitalizations 62 111
Average Patient Age 49.7 yrs 37.3 yrs
% Female Patients 81.1% 50.0%
FDA Approval Date Apr 23, 2008 N/A
Manufacturer Bausch Health US, LLC Kyowa Kirin, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription N/A